(Q36950474)

17 August 2017

1 reference

title

Late oral complications following radiotherapy for head and neck cancers (English)

1 reference

17 August 2017

Daniel T T Chua

1

1 reference

17 August 2017

Ye Tian

series ordinal

2

1 reference

17 August 2017

William I Wei

series ordinal

3

1 reference

17 August 2017

publication date

1 September 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

1215-1224

1 reference

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Partial irradiation of the parotid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Does amifostine have a role in chemoradiation treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Trismus in head and neck oncology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

A pilot study of pentoxifylline in the treatment of radiation-induced trismus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Radiotherapy-induced mandibular bone complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Side effects and quality of life after inadvertent radiation overdosage in brachytherapy of head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.9.1215

10.1586/14737140.7.9.1215

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference